Rac1+ cells distributed in accordance with CD 133+ cells in glioblastomas and the elevated invasiveness of CD 133+ glioma cells with higher Rac1 activity

Chinese Medical Journal

Volumn 125, Issue 24, 2012, Pages 4344-4348

  Zhang, Bin ^a   Sun, Jian ^a   Yu, Sheng Ping ^a   Chen, Cong ^a   Liu, Bin ^a   Liu, Zhi Feng ^a   Ren, Bing Cheng ^a   Ming, Hao Lang ^a   Yang, Xue Jun ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

Glioblastoma; Invasion; Migration; Rac1; Stem cells

Indexed keywords

CD133 ANTIGEN; RAC1 PROTEIN;

CANCER INVASION; CANCER RESISTANCE; CANCER STEM CELL; CELL MIGRATION; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; GLIOBLASTOMA; HUMAN; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REVIEW;

ANTIGENS, CD; CELL LINE, TUMOR; GLIOBLASTOMA; GLIOMA; GLYCOPROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; PEPTIDES; RAC1 GTP-BINDING PROTEIN;

EID: 84874287617     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2012.24.005     Document Type: Review

References (19)

1. Wen PY, Kesari S. Malignant gliomas in adults. N Engl J Med 2008; 359: 492-507.
2. Nakada M, Nakadaa S, Demutha T, Tran NL, Hoelzinger DB, Berens ME. Molecular targets of glioma invasion. Cell Mol Life Sci 2007; 64:458-478.
3. Gritsenko PG, llina O, Friedl P. Interstitial guidance of cancer invasion. J Pathol 2012; 226: 185-199.
4. Sanai N, Alvarez-Buylla A, Berger MS. Neural stem cells and the origin of gliomas. N Engl J Med 2005; 353: 811-822.
5. Vigil D, Cherfils J, Rossman KL, Der CJ. Ras superfamily GEFs and GAPs: validated and tractable targets for cancer therapy? Nat Rev Cancer 2010; 10: 842-857.
6. Yilmaz M, Christofori G Mechanisms of motility in metastasizing cells. Mol Cancer Res 2010; 8: 629-642.
7. Yu SP, Yang XJ, Zhang B, Ming HL, Chen C, Ren BC, et al. Enhanced invasion in vitro and the distribution patterns in vivo of CD133 glioma stem cells. Chin Med J 2011; 124: 2599-2604.
8. Azab AK, Azab F, Blotta S, Pitsillides CM, Thompson B, Runnels JM, et al. RhoA and Rac1 GTPases play major and differential roles in stromal cell-derived factor-1-induced cell adhesion and chemotaxis in multiple myeloma. Boold 2009; 114:619-629.
9. Pan Q, Yang XJ, Wang HM, Dong XT, Wang W, Li Y, et al. Chemoresistance to temozolomide in human glioma cell line U251 is associated with increased activity of 06-methylguanine-DNA methyltransferase and can be overcome by metronomic temozolomide regimen. Cell Biochem Biophy 2012; 62: 185-191.
10. Keunen O, Johansson M, Oudin A, Sanzey M, Rahim SA, Fack F, et al. anti-VEGF treatment reduces blood supply and increases tumor cell invasion in glioblastoma. Proc Natl Acad Sci U S A 2011; 108: 3749-3754.
11. Bergers G Hanahan D. Modes of resistance to anti-angiogenic therapy. Nat Rev Cancer 2008; 8: 592-603.
12. Bikfalvi A, Moenner M, Javerzat S, North S, Hagedorn M. Inhibition of angiogenesis and the angiogenesis/invasion shift. Biochem Soc Trans 2011; 39: 1560-1564.
13. Son MJ, Woolard K, Nam DH, Lee J, Fine HA. SSEA-1 is an enrichment marker for tumor-initiating cells in human glioblastoma. Cell Stem Cell 2009; 4: 440-452.
14. Singh SK, Clarke ID, Terasaki M, Bonn VE, Hawkins C, Squire J, et al. Identification of a cancer stem cell in human brain tumors. Cancer Res 2003; 63: 5821-5828. (Pubitemid 37187480)
15. Hide T, Takezaki T, Nakamura H, Kuratsu J, Kondo T. Brain tumor stem cells as research and treatment targets. Brain Tumor Pathol 2008; 25: 67-72.
16. Etienne-Manneville S, Hall A. Rho GTPases in cell biology. Nature 2002; 420: 629-635. (Pubitemid 36764489)
17. lwadate Y, Sakaida T, Saegusa T, Hiwasa T, Takiguchi M, Fujimoto S, et al. Proteome-based identification of molecular markers predicting chemosensitivity to each category of anticancer agents in human gliomas. Int J Oncol 2005; 26: 993-998.
18. Zhang B, Yang XJ, Yu SP, Ming HL, Chen C, Ren BC, et al. The role of Rac1 in SDF-l-induced the human glioma cell line U251 migration and invasion. Natl Med J China (Chin) 2012; 92:727-730.
19. Zagzag D, Esencay M, Mendez O, Yee H, Smirnova I, Huang Y, et al. Hypoxia- and vascular endothelial growth factor-indQced stromal cell-derived factor-lalpha/CXCR4 expression in glioblastomas: one plausjble explanation of Scherer's structures. Am J Pathol 2008; 173: 545-560.